Startup, 2007 Global Finals
LinkedIn

Formed in 2002, Insilicos is developing new biomarkers with the potential to revolutionize medicine, by providing better diagnoses of disease, and by enabling development of new therapies. Insilicos applies pattern-recognition techniques to proteomics. The initial focus is diagnostics and drug research related to cardiovascular disease.